News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021
News Conference News TCT 2021 Debating ISCHEMIA: Do the Results Apply to CABG, Too? Michael O'Riordan November 10, 2021
News Conference News TCT 2021 Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM Michael O'Riordan November 04, 2021
News Conference News TCT 2021 FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD Michael O'Riordan November 04, 2021
News Opinion Off Script From the Dress Rehearsal to Closing Night: Lessons in Humility and Hope Ankur Kalra June 15, 2021
News Daily News In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition Michael O'Riordan December 11, 2020
News Features Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI? Michael O'Riordan December 02, 2020
News Conference News ACC 2020 PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years Michael O'Riordan March 30, 2020
News Daily News Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL Michael O'Riordan January 17, 2020
News Opinion Editor's Corner ISCHEMIA Questions? Some Answers From David Maron Shelley Wood December 09, 2019
News Daily News STICH Myocardial Viability at 10 Years: Still No Link With CABG Effects Todd Neale August 21, 2019
News Daily News ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD Michael O'Riordan March 01, 2019
News Daily News FARGO: FFR No Help for CABG in Patients With Multivessel Disease L.A. McKeown November 27, 2018
News Conference News EuroPCR 2018 ‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease Yael L. Maxwell May 22, 2018
News Daily News iFR Pullback Provides Roadmap for CAD Severity, Predicts Hemodynamics Post-PCI Caitlin E. Cox April 17, 2018
News Daily News Fewer Complications, Lower Risk of Death With Conscious Sedation for TAVR Michael O'Riordan March 27, 2018
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Conference News TCT 2016 COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events Michael O'Riordan November 01, 2016